Zoom Logo

Tele-trials: Increasing access to clinical trials for improved health outcomes - Shared screen with speaker view
Nicole Phelan
16:07
Welcome to this evening Tele-trials: Increasing access to clinical trials for improved health outcomes
Nicole Phelan
16:35
If you have any technical issues please let me know here
Nicole Phelan
17:04
If you have any questions you would like to ask the Panellist please pop them into the Q&A box on your screens :)
Irini Agollari
18:10
Hi all, Please mute yourself to avoid background noise. Many thanks, I look forward to this webinar and the insights it will provide. Thanks Irini Agollari
Nicole Phelan
19:17
Yes you are already muted and cameras off :)
Kirsten Jackson
19:43
Hi all. Our Telehealth Hub can be found here - https://digitalhealthcrc.com/telehealth/
Nicole Phelan
33:11
If you have any questions you would like to ask the Panellist please pop them into the Q&A box on your screens :)
Suzanne Kapp
37:59
Thank you. I am enjoying the discussion. Are you referring to only RCTs when you discuss ‘tele-trials’? Or does the term usually encompass other designs? And can you comment on tele-trials outside the acute care setting, e.g. residential aged care? Suzanne, Nursing, University of Melbourne.
Rob Zielinski
39:10
COVID has been the mother of all inventions. Teletrials have been given a real positive push with the acceptance by Sponsors, Ethics and Governance groups about how you can perform usual care very well via telehealth
Craig Underhill
59:15
telehealth is just a tool, all trials could include components of care delivered by telehealth as part of a trial.
Nicole Phelan
01:00:25
If you have any questions you would like to ask the Panellist please pop them into the Q&A box on your screens :)
Craig Underhill
01:07:30
the monitoring can be done at the central site if they are recording source data. All monitoring can be done remotely.
Kate Bunyan
01:22:36
The current global population is approximately 7.8 billion. There are 3.9 billion smartphone owners globally at the moment. The opportunity to build accessibility for health care and trials is enormous
Ellen Yeo
01:29:07
Thank you Nicole
Kate Bunyan
01:41:32
Thank you so much for this session; it has been brilliant to listen to the dialogue and the quality of the questions, all being really well chaired